TrialOpen forum infectious diseases2025

Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment.

Claudio Díaz-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.